IMCD N.V. (NL:IMCD)
:IMCD
Want to see NL:IMCD full AI Analyst Report?
Top Page
IMCD N.V.
(IMCD)
Select Model
Select Model
Rating:64Neutral
Price Target:
€101.00
▲(5.87% Upside)
Action:Reiterated
Date:02/20/26
The score is primarily driven by fundamentally solid but recently pressured financial performance: cash flow quality is strong, but 2025 shows clear margin deterioration and slightly weaker revenue, alongside higher leverage. Technicals are improving in the short-to-medium term but remain below the 200-day trend, and valuation looks only fair at ~23x earnings with a moderate dividend yield.
Positive Factors
Strong free cash flow
Consistent one-to-one free cash flow conversion demonstrates durable cash generation that supports reinvestment, dividends, and debt reduction. Reliable FCF cushions the business through cyclical dips in revenue or margins and funds strategic initiatives without immediate external financing.
Negative Factors
2025 margin deterioration
Material margin compression in 2025 erodes operating leverage and free cash flow potential. If driven by structural pricing pressure, adverse mix, or less favorable supplier terms, lower margins can persist for quarters, weakening reinvestment capacity and returns to shareholders.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong free cash flow
Consistent one-to-one free cash flow conversion demonstrates durable cash generation that supports reinvestment, dividends, and debt reduction. Reliable FCF cushions the business through cyclical dips in revenue or margins and funds strategic initiatives without immediate external financing.
Read all positive factors
IMCD N.V. (IMCD) vs. iShares MSCI Netherlands ETF (EWN)
Market Cap
€5.30B
Dividend Yield2.83%
Average Volume (3M)255.76K
Price to Earnings (P/E)24.4
Beta (1Y)0.97
Revenue Growth1.08%
EPS Growth-24.24%
CountryNL
Employees5,126
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)3.69
Shares Outstanding59,107,998
10 Day Avg. Volume216,740
30 Day Avg. Volume255,764
Financial Highlights & Ratios
PEG Ratio-0.86
Price to Book (P/B)2.24
Price to Sales (P/S)0.96
P/FCF Ratio14.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€104.33Price Target Upside9.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)5.4
Revenue Forecast (FY)€5.08B
IMCD N.V. Business Overview & Revenue Model
Company Description
IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company offers enzymes, surfactants, biocides, chela...
How the Company Makes Money
IMCD makes money primarily by distributing specialty chemicals and ingredients on behalf of producers and selling them to manufacturers across multiple end markets. Its core revenue model is based on earning a gross profit margin (the difference b...
IMCD N.V. Financial Statement Overview
Summary
Income Statement
66
Positive
Balance Sheet
61
Positive
Cash Flow
72
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.78B | 4.73B | 4.44B | 4.60B | 3.44B |
| Gross Profit | 471.80M | 1.20B | 1.12B | 1.15B | 836.32M |
| EBITDA | 514.17M | 589.14M | 566.90M | 574.63M | 394.79M |
| Net Income | 217.58M | 278.24M | 292.27M | 313.08M | 207.28M |
Balance Sheet | |||||
| Total Assets | 4.64B | 4.88B | 4.15B | 3.64B | 3.27B |
| Cash, Cash Equivalents and Short-Term Investments | 238.59M | 522.78M | 394.46M | 222.00M | 177.88M |
| Total Debt | 1.70B | 1.73B | 1.28B | 722.60M | 409.63M |
| Total Liabilities | 2.59B | 2.66B | 2.43B | 1.97B | 1.81B |
| Stockholders Equity | 2.04B | 2.21B | 1.72B | 1.67B | 1.46B |
Cash Flow | |||||
| Free Cash Flow | 309.24M | 252.76M | 382.54M | 277.58M | 177.55M |
| Operating Cash Flow | 322.28M | 279.21M | 420.01M | 298.84M | 196.26M |
| Investing Cash Flow | -455.74M | -387.95M | -394.59M | -255.36M | -196.13M |
| Financing Cash Flow | -117.39M | 247.06M | 216.97M | -20.00K | 4.73M |
IMCD N.V. Technical Analysis
Positive
95.40
Price Trends
90.66
Negative
84.46
Positive
84.46
Positive
Market Momentum
-0.84
Positive
44.22
Neutral
18.25
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:IMCD, the sentiment is Positive. The current price of 95.4 is above the 20-day moving average (MA) of 93.77, above the 50-day MA of 90.66, and above the 200-day MA of 84.46, indicating a neutral trend. The MACD of -0.84 indicates Positive momentum. The RSI at 44.22 is Neutral, neither overbought nor oversold. The STOCH value of 18.25 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NL:IMCD.
IMCD N.V. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | €5.30B | 24.40 | 10.83% | 2.83% | 1.08% | -24.24% | |
60 Neutral | €11.36B | 18.32 | 14.61% | 3.38% | -7.05% | 32.41% | |
59 Neutral | €1.14B | 15.24 | 8.84% | 3.50% | -1.61% | 38.58% | |
57 Neutral | €2.56B | 13.10 | 11.48% | 7.57% | -8.69% | -42.98% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | €788.80M | 0.34 | ― | 229.25% | ― | ― | |
46 Neutral | €229.63M | -8.64 | -26.08% | ― | -30.63% | 43.45% |
* General Sector Average
NL:IMCD
IMCD N.V.
89.82
-25.76
-22.29%
NL:AKZA
Akzo Nobel NV
66.44
9.42
16.52%
NL:AVTX
Avantium N.V.
9.11
-0.68
-6.97%
NL:CRBN
Corbion NV
19.73
1.42
7.75%
NL:OCI
OCI N.V.
3.74
-1.17
-23.79%
NL:LIGHT
Signify NV
21.26
1.34
6.70%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.